First Solar, Inc. to Announce Third Quarter 2026 Financial Results - FIRST SOLAR INC

Financial Performance:

• Net sales for Q3 2026 reached approximately $1.2 billion, representing a 23% year-over-year decline primarily due to lower third-party module volumes.
• Gross margin expanded significantly to approximately 58% (up ~20 percentage points YoY), driven by a high mix of U.S.-produced modules, lower sales rates, and reduced utilization costs, partially offset by lower termination-related revenue.
• Adjusted EBITDA was $744 million, landing near the upper end of the prior guidance range, with an Adjusted EBITDA margin of roughly 60%.
• Net income rose 25% YoY to $571 million; Diluted EPS was $5.30 compared to $4.24 in the prior year.
• Operating expenses were $167 million, with R&D spending at $67 million reflecting continued investment in perovskite technology.
• The company ended the quarter with approximately $1.5 billion in net cash, maintaining its target range of $1.5–$2.0 billion, supported by $1.9 billion in government grant receivables (mostly U.S. ITC credits).
• Revenue guidance was lowered for 2026 reflecting reduced domestic and international Series 6 volumes sold, though the range for fully domestic product sold remains unchanged.

Guidance and Future Outlook:

• Full-year 2026 adjusted EBITDA guidance was lowered to reflect a reduction in India domestic volume (approx. 0.7 GW cut) and lower Series 6 international product sales.
• Future growth is projected to be driven by the Section 232 proclamation, AI infrastructure demand, and onshoring trends, with expectations for improved pricing and contract structures in 2029 and beyond.
• South Carolina Series 6 finishing facility is expected to reach commercial launch in mid-2027; India Series 7 conversions are set to begin Q1 2027, with 2027 India finished good production forecast between 2.2–2.6 GW.
• The Ohio pilot line for Series 6-sized perovskite modules is on track for operational readiness in H1 2027, followed by field deployment to validate performance.
• A decision on the long-term operating path for the Malaysia facility (12.8 GW capacity) is expected in H1 2027, with a binary outcome of near-full capacity or shutdown based on unit economics and trade conditions.
• 2027 core operating expenses are expected to increase due to IP defense legal costs and higher perovskite R&D spend (budget revised from $100M to $120M), offset by delays in South Carolina startup expenses, keeping total 2026 OpEx guidance unchanged.

Business Segments and Product Lines:

• U.S. Manufacturing: Series 7 conversion replication is underway, starting with the India facility to refine the process before U.S. deployment. Nearly 80% of the global manufacturing footprint is expected to be U.S.-based by 2027.
• Backlog: Ended Q3 with 44 GW in contracted backlog ($13.5B value) with deliveries extending through 2030.
• Bookings: Added approximately 1.4 GW in U.S. gross bookings at an average selling price (ASP) of ~36 cents/watt (inclusive of technology adjusters); roughly 4 GW of variable volume remains from pre-Section 232 contracts with decision dates spread through 2028.
• Product Mix: Pricing varies significantly by product series and origin; Series 7 U.S. domestic products command higher ASPs than international finished goods from Malaysia or India.
• Technology: Advanced perovskite R&D continues via licensing agreements with Cubic PV and Oxford PV; Series 7 "CURE" technology deployment is a key value driver through technology adjusters.

Market and Competitive Landscape:

• Section 232: The August proclamation is viewed as a structural shift favoring U.S. manufacturing, reducing reliance on Chinese supply chains and adversarial nations.
• Demand Drivers: Load growth from AI data centers and electrification is driving demand for utility-scale solar; customers prioritize bankable warranties, delivery certainty, and supply chain security.
• Competitive Position: First Solar differentiates as the only fully integrated utility-scale manufacturer without dependency on a Chinese crystalline silicon supply chain; customers express concern over the "FIAC-free" status of competitors with Chinese ties.
• Pricing Environment: A "price discovery" phase is ongoing post-Section 232; new deals negotiated after the announcement reflect increased pricing, while existing variable volume remains at pre-announcement levels.

Risks and Challenges:

• Booking Volatility: Shift from multi-year framework agreements to project-specific contracts has moderated volume booking pace, though economic terms (pricing) are improving.
• Regulatory Uncertainty: Unclear final FERC guidance, evolving Section 232 implementation (Minimum Import Prices, anti-stockpiling), and potential exclusions create uncertainty for customers.
• Project Economics: Rising battery costs, inflation, NIMBYism, and state/local opposition to data centers and transmission are delaying customer procurement decisions.
• Malaysia Facility: The binary decision on the Malaysia facility creates operational risk, though its limited footprint and lack of Section 45X eligibility minimize earnings impact.
• Enforcement Risks: Aggressive attempts by importers to bypass tariffs (stockpiling) despite Commerce Department enforcement actions create market distortion risks.

Management Commentary and Tone:

• Management expressed "disciplined" execution, confidence in long-term value, and a shift toward higher-quality project-specific contracts over broad frameworks.
• The tone was confident regarding the structural benefits of Section 232 and the company's U.S. manufacturing advantage, despite near-term booking headwinds.
• Management emphasized a strategic pivot to optimize pricing and contract structures to mitigate external cost risks, rather than sacrificing volume for speed.
• Board authorized a $500 million share repurchase program with no expiration, signaling confidence in capital return capabilities while preserving cash for R&D and growth.

Analyst Questions and Answers:

• 2029 Booking Urgency: Management clarified that lack of urgency in booking 2029 volumes is due to customers focusing on near-term 2028 safe harbor completion, regulatory clarity, and local permitting challenges, not a lack of demand.
• Post-232 Pricing: Deals initiated after the Section 232 announcement have seen pricing increases; the market is currently in a discovery phase with no fixed long-term benchmark for late-decade volumes.
• Contract Strategy: The company is shifting from framework agreements to project-specific contracts to improve operational efficiency, reduce inventory/working capital costs, and gain delivery certainty.
• Malaysia Operations: The decision to operate or shut down the Malaysia facility will be made in H1 2027 based on visibility of international demand and Section 232 impacts; currently, it serves as an option value for international volume.
• Tax Credits: $1.9B in ITC receivables are being actively managed, with potential monetization sales balanced against holding for refundability; refund processing time is historically short (approx. 3 months).
• Series 7 vs. Competitors: Series 7 CURE is projected to be advantageous against perovskite and slightly disadvantaged (few cents) against TopCon due to bifaciality factors, but significantly advantaged regarding supply chain security and lack of quality factors in energy modeling.
• SWIFT Lawsuit: Management confirmed a response is imminent, stating they will adhere to limited liability warranties and remedy Series 7 issues within those parameters but will not accept remedies outside the agreement.

Other Key Points:

• Capital Allocation: Priorities remain maintaining $1.5–$2.0B net cash, investing in R&D/technology, and deploying excess cash into M&A or share repurchases.
• Intellectual Property: Continued legal defense of TopCon IP and perovskite IP partnerships (Cubic, Oxford) to support future revenue and market positioning.
• Operational Efficiency: Moving to project-specific contracting allows for better inventory planning, reducing storage costs and working capital drag associated with volatile framework schedules.